Project Details
Description
A Randomized, Double-Blinded Phase II Study of Maintenance Pembrolizumab versus Placebo after Firstline Chemotherapy in Patients with Metastatic Urothelial Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/16 → 5/31/21 |
Funding
- HOOSIER CANCER RESEARCH NETWORK, INC
- MERCK AND CO INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.